Peter T. Scardino

Dr. Peter T. Scardino (born 1945) is an American cancer surgeon, researcher, and author expert in genitourinary and urological cancers particularly cancer of the prostate. As chair of the Department of Surgery[1] at Memorial Sloan Kettering Cancer Center in New York City, Scardino oversees a team that has developed surgical techniques to preserve patients’ urinary and sexual function following prostatectomy. Scardino is known for his work on identifying tissue and genetic markers that reveal information about the behavior of prostate cancer and has spoken about the disease in the media. He and his colleagues introduced statistical models called nomograms that predict both the natural progression of prostate cancer and its response to treatment.[2] Today, nomograms are being used to assist in medical decisions about a variety of cancers of the pancreas, lungs, and breast.[3]

Life and work

Scardino earned his baccalaureate degree at Yale University and his M.D. at the Duke University School of Medicine. He held surgical residencies at Massachusetts General Hospital in Boston and the University of California. He taught at University of California (Los Angeles UCLA) and at Baylor College of Medicine in Houston.

Scardino joined Memorial Sloan-Kettering in New York in 1998, as head of MSKCC’s Prostate Cancer Program and chief of the Urology Service, where he was awarded the Murray F. Brennan Chair in Surgery. He currently holds the David H. Koch Chair. He became Chair of the Department of Surgery in 2006.[4] He is also a professor in the Department of Urology at Weill Cornell Medical College[5] and at SUNY Downstate Medical Center.[6]

In line with his work on genetic markers, Scardino in 2001 received a grant from the National Institutes of Health to create a new program in prostate cancer at MSKCC called SPORE, or Specialized Program of Research Excellence.[7] The program focuses on translating information gained in the laboratory into clinical investigation and patient care.[8]

Scardino has written extensively about his field and is editor of The Comprehensive Textbook of Genitourinary Oncology, now in its fourth edition; he was co-writer, with Judith Kelman, of the 2005 (and recently updated) consumer book, Dr. Peter Scardino’s Prostate Book The Completed Guide to Prostate Cancer, Prostatitis, and Benign Prostate Hyperplasia.

Awards

Scardino received the Barringer Medal from the American Association of Genitourinary Surgeons in 2009.[9][10] The American Urological Association awarded Scardino its Distinguished Contribution Award in 2008. And he received the Society of Urologic Oncology Medal in 2005.[11]

Publications

References

  1. ↑ "Peter Scardino Named Chairman of Surgery | Memorial Sloan-Kettering Cancer Center". Mskcc.org. 2006-07-05. Retrieved 2012-02-28.
  2. ↑ Kattan, Michael; James A. Eastham; Alan M.F. Stapleton; Thomas M. Wheeler; and Peter T. Scardino. "A Preoperative Nomogram for Disease Reoccurrence Following Radical Prostatectomy for Prostate Cancer.". Oxford Journals, Medicine, Journal of the National Cancer Institutes 90 (10): 766–771.
  3. ↑ Glare, Paul (Sep–Oct 2005). "Clinical Predictors of Survival in Advanced Cancer". The Journal of Supportive Oncology 3 (5): 338.
  4. ↑ "Peter T. Scardino - Physician Profile | Memorial Sloan-Kettering Cancer Center". Mskcc.org. Retrieved 2012-02-28.
  5. ↑ "Faculty | Weill Cornell Medical College in New York City | Cornell University". Weill.cornell.edu. Retrieved 2012-02-28.
  6. ↑ "Faculty Members". Downstate.edu. Retrieved 2012-02-28.
  7. ↑ "Private Health Management : Peter T. Scardino". Privatehealth.com. Retrieved 2012-02-28.
  8. ↑ "Change in PSA Level Does Not Predict Cancer, Study Finds". ScienceDaily. Feb 24, 2011.
  9. ↑ "Awards". AAGUS. Retrieved 2012-02-28.
  10. ↑ "AAGUS". AAGUS. Retrieved 2012-02-28.
  11. ↑ "(SUO)". Society of Urologic Oncology. Retrieved 2012-02-28.

External links